Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Bioequivalence Study to Compare Brexpiprazole 4 mg Film Coated Tablets Versus RXULTI 4 mg Film Coated Tablet (Brexpiprazole) [Phase 1]
Phase 1 bioequivalence study comparing Brexpiprazole 4 mg film-coated tablets to RXULTI 4 mg tablets has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Bioequivalence Study of Long-Acting Paliperidone Palmitate in Patients With Schizophrenia [NA]
This clinical trial update reports the completion of a bioequivalence study of long-acting paliperidone palmitate in patients with schizophr…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: nTMS for Negative Symptom in Schizophrenia [NA]
A clinical trial evaluating navigated transcranial magnetic stimulation (nTMS) for negative symptoms in schizophrenia is currently recruitin…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Validation of a VOICE MAnagement Program in Schizophrenia VVoice MAPS [NA]
Clinical trial validating a VOICE Management Program for schizophrenia; status is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Oxytocin-Augmented Group Psychotherapy for Patients With Schizophrenia - an Oxytocin-dose Comparison [NA]
An ongoing study at Charité University in Berlin is evaluating oxytocin-augmented group psychotherapy for schizophrenia spectrum disorders, …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Imagery Rescripting as a Treatment for Early Psychosis [NA]
This clinical trial update describes a study evaluating imagery rescripting as a treatment for early psychosis. The trial is currently activ…
-
FDA approval · 2025-12-03FDA Approved: OLANZAPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for olanzapine from Torrent Pharmaceuticals Limited (ANDA 091415), expanding access to a generic ola…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Feasibility and Acceptability of Mobile Mental Health App for SZ and SZA [NA]
A University of Pittsburgh trial is evaluating the feasibility and acceptability of a mobile mental health app for schizophrenia and schizoa…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Prucalopride for Cognitive Functioning in Schizophrenia [NA]
A ClinicalTrials.gov entry describes a study investigating prucalopride for improving cognitive functioning in individuals with schizophreni…
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: Atypical Antipsychotic-induced Mitochondrial Dysfunction in Patients With Schizophrenia [Phase 4]
Phase 4 clinical trial investigating mitochondrial dysfunction associated with atypical antipsychotics in schizophrenia; the study has compl…
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: Implementing mHealth for Schizophrenia in Community Mental Health Settings [NA]
Completed clinical trial evaluating mobile health tools to support schizophrenia management in community mental health settings; results hav…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Targeting Processing Speed Deficits to Improve Social Functioning and Lower Psychosis Risk [NA]
A Northwell Health-sponsored clinical trial is recruiting to test approaches that target processing speed deficits to improve social functio…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: A Study to Assess the Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Chinese Adult Subjects With DSM-5 Schizophrenia [Phase 3]
Phase 3 trial evaluating KarXT for acutely psychotic schizophrenia in Chinese adults has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: Effect of Immersive Virtual Reality-based Cognitive Remediation in Patients With Mood - or Psychosis Spectrum Disorders [NA]
A completed clinical trial assessing immersive virtual reality–based cognitive remediation for mood- and psychosis-spectrum disorders.
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Feeling Safe Study [NA]
A clinical trial update indicates a recruiting study sponsored by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, in…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020 [Phase 1]
Luye Pharma Group is conducting a Phase 1 multiple ascending dose study to assess the safety and tolerability of LY03020. The trial targets …
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: CAE for Poorly Adherent Individuals With Schizophrenia [NA]
A clinical trial evaluating CAE for poorly adherent individuals with schizophrenia has completed and posted results on 2025-11-18.
-
FDA approval · 2025-11-18FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' generic fluphenazine hydrochloride under an ANDA, expanding access to this antipsychotic used to treat …
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Exercise-based Program for Rehabilitation of Veterans With Severe Mental Illness [NA]
A VA-sponsored clinical trial is evaluating an exercise-based rehabilitation program for veterans with schizophrenia, schizoaffective disord…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: The Purpose of This Study is to Determine the Safety, Tolerability, and Pharmacokinetics of Brexpiprazole Long-acting Injection Following a Single Administration in Healthy Subjects/Patients With Schizophrenia. [Phase 1]
A Phase 1 clinical trial to assess safety, tolerability, and pharmacokinetics of a single-dose long-acting injectable brexpiprazole in healt…
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: A Clinical Study That Will Evaluate How Well SEP-363856 Works and How Safe it is in People With Schizophrenia That Switch to SEP-363856 From Their Current Antipsychotic Medication [Phase 3]
A Phase 3 trial evaluating SEP-363856 (ulotaront) for schizophrenia in patients switching from their current antipsychotic has completed and…
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of Lumateperone in Pediatric Patients With Schizophrenia or Schizoaffective Disorder [Phase 1]
Phase 1 study evaluating safety, tolerability, and pharmacokinetics of lumateperone in pediatric patients with schizophrenia or schizoaffect…
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: Ketogenic Diet in People With Schizophrenia [NA]
A clinical trial is investigating the effects of a ketogenic diet in people with schizophrenia and schizoaffective disorder; the study is cu…
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: An Extension Study to a Clinical Study That Will Continue to Evaluate the Effectiveness and Safety of SEP-363856 in People With Schizophrenia That Switch to SEP-363856 From Their From Their Current Antipsychotic Medication [Phase 3]
This document reports results from an extension Phase 3 study of SEP-363856 in schizophrenia. It examines effectiveness and safety when pati…
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: Visual Perception in Schizophrenia [NA]
A University of Rochester trial is currently recruiting to study visual perception in schizophrenia and related disorders.